Arcutis Biotherapeutics, Inc. (ARQT) Financials

ARQT Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 488.5 million 268.0 million
March 31, 2026 460.0 million 270.4 million
Dec. 31, 2025 433.0 million 243.5 million
Sept. 30, 2025 371.0 million 212.9 million

ARQT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 12.5 million 12.8 million
March 31, 2026 2.2 million 10.7 million
Dec. 31, 2025 26.2 million 10.1 million
Sept. 30, 2025 -1.8 million 10.0 million

ARQT Net Income

No data available :(

ARQT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 238.6 million 102.0 million 5.2 million
March 31, 2026 224.0 million 101.5 million 5.3 million
Dec. 31, 2025 221.0 million 5.3 million 5.3 million
Sept. 30, 2025 191.1 million 107.5 million 5.3 million

ARQT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 135.9 million
March 31, 2026 129.4 million
Dec. 31, 2025 135.6 million
Sept. 30, 2025 132.9 million

ARQT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 158000 20.4 million 82.1 million -
March 31, 2026 - 30.6 million 74.1 million -
Dec. 31, 2025 - 20.5 million 79.0 million -
Sept. 30, 2025 - 19.6 million 62.4 million -

ARQT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 129.9 million 10.9 million
March 31, 2026 105.4 million 9.8 million
Dec. 31, 2025 129.5 million 11.7 million
Sept. 30, 2025 99.2 million 8.7 million

ARQT Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ARQT

Price: $26.19

52 week price:
13.70
31.77

Earnings Per Share: 0.22 USD

P/E Ratio: 119.23

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 827862

Market Capitalization: 3.3 billion

Links: